Suppr超能文献

SEDDS 中疏水离子对治疗性肽的泰勒分散分析测定的肽释放。

Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis.

机构信息

IBMM, University of Montpellier, CNRS, ENSCM, 34095 Montpellier, France.

IBMM, University of Montpellier, CNRS, ENSCM, 34095 Montpellier, France.

出版信息

Int J Pharm. 2019 Mar 25;559:228-234. doi: 10.1016/j.ijpharm.2019.01.039. Epub 2019 Jan 28.

Abstract

Therapeutic peptides are facing an increasing interest as drugs for the treatment of many diseases. The challenge in the administration of such drugs, due to inherent properties of these peptides, is to make them bioavailable. Self-emulsifying drug delivery systems (SEDDS) are considered a suitable and promising strategy to deliver the peptides and increase their bioavailability. However, to enter into the SEDDS nanodroplets, the peptides must be made hydrophobic by complexation with surfactants (formation of hydrophobic ion pair, HIP). The aim of this work is to assess the possibility to quantify the amount of released peptides and of the remaining docusate/peptide HIP in the nanodroplets by Taylor Dispersion Analysis (TDA) on two therapeutic peptides (leuprorelin and desmopressin). It also clearly demonstrates that the logP value of the peptide has a strong influence on the extent of HIP inside of the SEDDS nanodroplets. For instance leuprorelin-docusate complex (logP = 3) was 100% inside of the nanodroplets at low ionic strength, while for desmopressin-docusate complex (logP = 0.5) only 30% were able to enter the nanodroplets. It was also shown that an increase in the ionic strength of the release media allowed to increase the amount of released peptide up to 80% for leuprorelin and 100% for desmopressin, at physiological ionic strength. TDA experiments allowed to determine the partitioning coefficient, logD value, of the peptide between the SEDDS and continuous aqueous phases. In conclusion, this work demonstrates that TDA is a rapid, straightforward and useful technique for developing SEDDS formulations.

摘要

治疗性肽作为治疗许多疾病的药物越来越受到关注。由于这些肽的固有特性,在给予这些药物时,面临的挑战是使它们具有生物利用度。自乳化药物传递系统(SEDDS)被认为是一种合适且有前途的策略,可以递送电 ,增加其生物利用度。然而,为了进入 SEDDS 纳米液滴,必须通过与表面活性剂(形成疏水离子对,HIP)络合使肽疏水。本工作的目的是评估通过泰勒分散分析(TDA)对两种治疗性肽(亮丙瑞林和去氨加压素)来定量释放的肽和剩余的十二酸/肽 HIP 的可能性。它还清楚地表明,肽的 logP 值对 HIP 在 SEDDS 纳米液滴中的程度有很强的影响。例如,亮丙瑞林-十二酸复合物(logP=3)在低离子强度下 100%在纳米液滴内,而对于去氨加压素-十二酸复合物(logP=0.5)只有 30%能够进入纳米液滴。还表明,释放介质中离子强度的增加允许将亮丙瑞林释放的肽的量增加到 80%,而去氨加压素的量增加到 100%,在生理离子强度下。TDA 实验允许确定肽在 SEDDS 和连续水相之间的分配系数,logD 值。总之,这项工作表明 TDA 是一种快速、直接和有用的开发 SEDDS 制剂的技术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验